The 9th World Congress of Melanoma (WCM) was held in Brisbane, Australia, from 18 to 21 October. In a series of interviews medical professionals from all over the world discussed the latest developments in the field of melanoma.
This highlight consists of the following parts:
- Jeffrey Gershenwald, MD – surgical-oncologist, MD Anderson Cancer Center, Houston, USA: The new AJCC melanoma classification
- Prof. John Thompson, MD – surgical-oncologist, The University of Sydney, Sydney, Australia: Surgery for stage IV melanoma patients: is it still worthwhile?
The interviews are editorially independent and are financially supported by BMS, Incyte, MSD and Novartis.